LNTH Stock Analysis: Buy, Sell, or Hold?
LNTH - Lantheus Holdings, Inc
$95.83
-0.63 (-0.65%)
▼
5d:
+5.31%
30d:
+14.16%
90d:
+39.45%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When LNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called LNTH this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: LNTH is 10.3% above its trading range ($86.86). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: LNTH is 10.3% above its trading range ($86.86). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$137.76
Based on 12.0% avg growth
INTRINSIC VALUE TODAY
$85.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LNTH is currently trading at $95.83, which is considered extended relative to its 30-day fair value range of $78.05 to $86.86. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.2) compared to its historical average (12.4). At these levels, the market is pricing in 6.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is approaching resistance at $98.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LNTH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is approaching resistance at $98.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LNTH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$78.05 -
$86.86
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.7%
Protect Your Profits
LNTH is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($103.62)
- NEUTRAL: Trading at premium valuation - market expects 6.9% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$78.05 -
$86.86
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$83.72
Resistance Level
$98.27
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.17
Wall Street Target
$103.62
(+7.4%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
76.5%
Profit Margin
18.1%
Valuation Premium vs History
+6.9% premium
PE vs Historical
15.2 vs 12.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.9%
(market-implied from PE analysis)
1-Year Target
$103.12
(+7%)
2-Year Target
$110.23
(+14%)
3-Year Target
$117.84
(+22%)
3-Yr Target (if PE normalizes)
(PE: 15→12)
PE COMPRESSION
$96.31
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 19.9%)
$241.81
(+151%)
Base:
(SPY PE: 15.2, Growth: 19.9%)
$166.45
(+73%)
Bear:
(PE: 12.4, Growth: 19.9%)
$136.04
(+41%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 22.45 | Current EPS (TTM): $4.19
Bull Case
$157.02
(+63%)
Analyst growth 51.7%, PE expands to 24.7
Base Case
$142.74
(+48%)
Market implied 51.7%, PE stable at 22.5
Bear Case
$63.97
(-34%)
Severe decline -20.0%, PE contracts to 19.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 14, 2026 2:43 PM ET
Data refreshes hourly during market hours. Next update: 3:43 PM
Data refreshes hourly during market hours. Next update: 3:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$136 | 60 BUY |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 56 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$40 | 57 HOLD |
Advanced LNTH Option Strategies
Professional options setups generated by AI based on today's LNTH price and gamma walls.
